Mandate

Vinge has advised the arrangers in connection with Heimstaden’s EUR 350,000,000 bond issuance

The banks acted as arrangers and bookrunners in connection with Heimstaden AB’s (publ) issuance of EUR 350,000,000 senior unsecured bonds, within a framework amount of EUR 450,000,000.

The bond proceeds are intended to be used for the purchase of equity in Heimstaden Bostad AB and general corporate purposes. In accordance with the terms and conditions, the bonds are intended to be listed on the corporate bond list of Nasdaq Stockholm.

Vinge’s team consisted of Louise Brorsson Salomon and Lionardo Ojeda (Banking and Finance) together with Jesper Schönbeck and Linnéa Sellström (Capital Markets and Public M&A).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025